RICHARD FITZSIMMONS: Open Payments
NPI 1275550709 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 29 payments from 12 companies in 2025. Trend: 2023 $288 · 2024 $345 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $507 |
| Novo Nordisk Inc | 6 | $180 |
| Madrigal Pharmaceuticals | 1 | $104 |
| ABBVIE INC. | 3 | $77 |
| Amgen Inc. | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Radius Health, Inc. | 2 | $36 |
| Averitas Pharma Inc. | 1 | $26 |
| CeQur Corporation | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
Products named: AIRSUPRA, Ozempic, BREZTRI, REZDIFFRA, OTEZLA, Kerendia, LINZESS, CREON.
Industry payments across CA — which companies pay providers there.
